Anavex Life Sciences Corp.
AVXL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001314052
No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.
Members of Congress who traded AVXL
Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.
- Trades
- 2
- Filings
- 2
- Members
- 1
- Buys / sells
- 1 / 1
- Estimated volume
- $16.0K
- Sum of range midpoints
| Member | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
| Chris JacobsRepublican · House · NY | 2 | 1 / 1 | $16.0K | Dec 12, 2022 | Jan 20, 2023 |
Trades
Every reported trade in Anavex Life Sciences Corp., newest filings first.
| Member | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
| Chris JacobsRepublican · House · NY | AVXLAnavex Life Sciences Corp. | Buy | Self | Oct 12, 2022 | Nov 16, 2022 | 35 days | $1K-$15K | Filing |
| Chris JacobsRepublican · House · NY | AVXLAnavex Life Sciences Corp. | Sell | Self | Dec 12, 2022 | Jan 20, 2023 | 39 days | $1K-$15K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.